C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Isabelle Le Ber; Agnès Camuzat; Lena Guillot-Noel; Didier Hannequin; Lucette Lacomblez; Véronique Golfier; Michèle Puel; Olivier Martinaud; Vincent Deramecourt; Sophie Rivaud-Pechoux; Stéphanie Millecamps; Martine Vercelletto; Philippe Couratier; François Sellal; Florence Pasquier; François Salachas; Catherine Thomas-Antérion; Mira Didic; Jérémie Pariente; Danielle Seilhean; Merle Ruberg; Isabelle Wargon; Frédéric Blanc; William Camu; Bernard-François Michel; Eric Berger; Mathilde Sauvée; Christel Thauvin-Robinet; Karl Mondon; Elisabeth Tournier-Lasserve; Cyril Goizet; Marie Fleury; Gabriel Viennet; Patrice Verpillat; Vincent Meininger; Charles Duyckaerts; Bruno Dubois; Alexis Brice

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Isabelle Le Ber ¹ Agnès Camuzat ¹ Lena Guillot-Noel ¹ Didier Hannequin ² Lucette Lacomblez ³ Véronique Golfier Michèle Puel ^{4, 5} Olivier Martinaud ² Vincent Deramecourt ⁶ Sophie Rivaud-Pechoux ⁷ Stéphanie Millecamps ¹ Martine Vercelletto ⁸ Philippe Couratier ^{9, 10} François Sellal ¹¹ Florence Pasquier ¹² François Salachas ¹³ Catherine Thomas-Antérion ¹⁴ Mira Didic ¹⁵ Jérémie Pariente ^{5, 4} Danielle Seilhean ¹⁶ Merle Ruberg ^{7, 17} Isabelle Wargon ¹⁸ Frédéric Blanc ¹⁹ William Camu ²⁰ Bernard-François Michel Eric Berger Mathilde Sauvée Christel Thauvin-Robinet ^{21, 22} Karl Mondon ²³ Elisabeth Tournier-Lasserve Cyril Goizet ²⁴ Marie Fleury ¹⁹ Gabriel Viennet ²⁵ Patrice Verpillat ⁷ Vincent Meininger ¹³ Charles Duyckaerts Bruno Dubois ¹ Alexis Brice ^{17, 1, *}

* Auteur correspondant

1 CRICM - Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière

2 GMFC - Génétique du cancer et des maladies neuropsychiatriques

3 LIF - Laboratoire d'Imagerie Fonctionnelle

4 Neurologie générale et maladies inflammatoires du système nerveux [Toulouse]

5 Imagerie cérébrale et handicaps neurologiques

6 Troubles cognitifs neurodégénératifs et vasculaires

7 Neurologie et thérapeutique expérimentale

8 Service de neurologie [Nantes]

9 NET - Neuroépidémiologie Tropicale

10 Service de Neurologie [CHU Limoges]

11 Service de neurologie

12 Service de Neurologie [Lille]

13 Fédération des Maladies du Système Nerveux

14 CMRR - Centre de Mémoire de Ressource et Recherche

15 Service de neurologie et de neuropsychologie

16 The Mediterranean Institute of Neurobiology

17 Service de Génétique Cytogénétique et Embryologie [CHU Pitié-Salpêtrière]

18 Physiologie et physiopathologie de la motricité chez l'homme

19 Service de Neurologie [Strasbourg]

20 SLA CHRU Montpellier - Centre référent Sclérose Latérale Amyotrophique [CHRU Montpellier]

21 Centre de génétique - Centre de référence des maladies rares, anomalies du développement et syndromes malformatifs (CHU de Dijon)

22 Department of Experimental Cardiology

23 Imagerie et cerveau

24 Service de génétique médicale

25 E2SNC / ESTROGENES - Estrogènes, Expression génique et pathologies du Système Nerveux Central - UFC

Abstract : Frontotemporal dementia (FTD) refers to a disease spectrum including the behavioral variant FTD (bvFTD), primary progressive aphasia (PPA), progressive supranuclear palsy/corticobasal degeneration syndrome (PSP/CBDS), and FTD with amyotrophic lateral sclerosis (FTD-ALS). A GGGGCC expansion in C9ORF72 is a major cause of FTD and ALS. C9ORF72 was analyzed in 833 bvFTD, FTD-ALS, PPA, and PSP/CBDS probands; 202 patients from 151 families carried an expansion. C9ORF72 expansions were much more frequent in the large subgroup of patients with familial FTD-ALS (65.9%) than in those with pure FTD (12.8%); they were even more frequent than in familial pure ALS, according to estimated frequencies in the literature (23-50%). The frequency of carriers in non-familial FTD-ALS (12.7%) indicates that C9ORF72 should be analyzed even when family history is negative. Mutations were detected in 6.8% of PPA patients, and in 3.2% of patients with a clinical phenotype of PSP, thus enlarging the phenotype spectrum of C9ORF72. Onset was later in C9ORF72 (57.4 years, 95%CI: 55.9-56.1) than in MAPT patients (46.8, 95%CI: 43.0-50.6; p = 0.00001) and the same as in PGRN patients (59.6 years; 95%CI: 57.6-61.7; p = 0.4). ALS was more frequent in C9ORF72 than in MAPT and PGRN patients; onset before age 50 and parkinsonism were indicative of MAPT mutations, whereas hallucinations were indicative of PGRN mutations; prioritization of genetic testing is thus possible. Penetrance was age- and gender-dependent: by age 50, 78% of male carriers were symptomatic, but only 52% of females. This can also guide genetic testing and counseling. A flowchart for genetic testing is thus proposed.

Type de document :

Article dans une revue

Domaine :

Sciences du Vivant [q-bio] / Santé publique et épidémiologie

Liste complète des métadonnées

https://hal-unilim.archives-ouvertes.fr/hal-00924796
Contributeur : Elisabeth Grelier <>
Soumis le : mardi 7 janvier 2014 - 10:53:59
Dernière modification le : mercredi 24 juillet 2019 - 09:02:03

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Identifiants

Collections

Citation

Exporter

Métriques

561

C9ORF72 repeat expansions in the frontotemporal dementias spectrum of diseases: a flow-chart for genetic testing.

Identifiants

Collections

Citation

Exporter

Partager

Métriques

561